Cart (Loading....) | Create Account
Close category search window
 

A High Yield Neutron Target for Cancer Therapy

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

2 Author(s)
Alger, Donald L. ; Lewis Research Center National Aeronautics and Space Administration Cleveland, Ohio ; Steinberg, Robert

A rotating target has been developed that has the potential for providing an initial yield of 1013 neutrons per second by the T(d,n) He4 reaction, and a useable lifetime in excess of 600 hours. This yield and lifetime are indicated for a 300 KV and 30 mA deuteron accelerator and a 30 ¿m thick titanium tritide film formed of the stoichiometric compound TiT2. The potential for extended lifetime is made possible by incorporating a sputtering electrode that permits use of titanium tritide thicknesses much greater than the deuteron range. The electrode is used to remove in situ depleted titanium layers to expose fresh tritide beneath. The utilization of the rotating target as a source of fast neutrons for cancer therapy is discussed.

Published in:

Nuclear Science, IEEE Transactions on  (Volume:20 ,  Issue: 1 )

Date of Publication:

Feb. 1973

Need Help?


IEEE Advancing Technology for Humanity About IEEE Xplore | Contact | Help | Terms of Use | Nondiscrimination Policy | Site Map | Privacy & Opting Out of Cookies

A not-for-profit organization, IEEE is the world's largest professional association for the advancement of technology.
© Copyright 2014 IEEE - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.